NFSG
LAB icon

Newbridge Financial Services Group’s Standard BioTools LAB Stock Holding History

Newbridge Financial Services Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-500
Closed -$3K – 1507
2021
Q2 		$3K Sell
500
-3,000
-86% -$16K ﹤0.01% 1219
2021
Q1 		$16K Buy
+3,500
New +$19.2K 0.01% 748

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Newbridge Financial Services Group's LAB Position: Q3 2021 in Review

Newbridge Financial Services Group sold out of Standard BioTools (LAB) in Q3 2021, closing a stake of 500 shares — an estimated $3K sold.

Newbridge Financial Services Group first reported a position in LAB in Q1 2021 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 119 funds tracked by Wall St. Rank hold LAB as of Q3 2021.

  • Newbridge Financial Services Group reported no remaining Standard BioTools position as of Q3 2021 after selling out during the quarter.
  • Newbridge Financial Services Group sold 500 Standard BioTools shares in Q3 2021, an estimated $3K.
  • Newbridge Financial Services Group first reported a position in Standard BioTools in Q1 2021 and held it in 2 quarters.
  • Newbridge Financial Services Group's Standard BioTools position peaked at $16K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2021.

Based on Newbridge Financial Services Group's 13F filing for Q3 2021, filed 27 Oct 2021.